Genpact announced today that it teamed up with Embecta (Nasdaq:EMBC) to support the company in the diabetes technology market. The company says it has been working with Embecta to support its spinoff from BD and subsequent evolution as a company. “From the beginning, our relationship was rooted in shared values and a commitment to mutual […]
